Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9286097Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Otolaryngology
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#4,677
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Guangyong Peng as a PI. Multi-PI records show the full award amount for context.
- 5R01CA237149-06R01Metabolic Control of Innate and Adaptive Immunity in Breast Cancer$420.2Kaward amount
- 5R01CA242188-06R01Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity$396.2Kaward amount
- 5R01AG078822-05R01Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease$388.8Kaward amount
- 5R01AI173260-04R01Excessive lipid metabolism in T cell senescence and immunosuppression$388.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Guangyong Peng as a PI.
FY2026 award administered by Washington University in St. Louis (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWashington University in St. Louis
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #4677
- 2026Entered Top 25% NationallyRanked #4677